No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“From two studies, we found no effect of melatonin on cognition or performance of activities of daily living (ADL).”
- Study
- meta-analysis
- Population
- patients with moderate-to-severe Alzheimer's disease dementia and an identified sleep disturbance, melatonin doses up to 10 mg; no specific ADL instrument named
Study record
- Design
- meta-analysis
- Species
- human
- Population
- adults with dementia (mostly Alzheimer's disease) with an identified sleep disturbance; 222 participants across four melatonin studies (two yielded meta-analysable data)
- Participants
- 222
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 5
melatonin